<ul data-eligibleForWebStory="true">ArisInfra has filed its red herring prospectus (RHP) to raise about INR 500 Cr from the public markets after receiving SEBI’s approval.The IPO will have a fresh issue component, aiming to raise INR 499.6 Cr.The company had initially intended to raise INR 600 Cr via the IPO but later reduced the size to INR 579.6 Cr.ArisInfra raised INR 80 Cr in a pre-IPO placement round earlier this year by issuing over 36 Lakh equity shares.The IPO subscription will open on June 17 and close on June 20, with the shares debuting on the BSE and NSE.The IPO proceeds will be utilized for debt repayment, working capital needs, subsidiary investment, and general corporate purposes.ArisInfra supplies construction materials to real estate and infrastructure developers and counts prominent clients like The Wadhwa Group and ACC.Founder Siddharth Shah's family trust is the largest shareholder in ArisInfra.The company is led by ex-Wadhwa Group COO Srinivasan Gopalan as CEO.ArisInfra turned profitable in the nine months of FY25 with a profit of INR 6.5 Cr, compared to a loss in FY24.The operating revenue for the period was INR 557.8 Cr.PharmEasy founder Siddharth Shah is involved in promoting ArisInfra.The founders of ArisInfra oversee the tech, business strategy, and day-to-day operations of the company.The company's total debt at the end of FY25 was INR 336.6 Cr, with plans to repay INR 204.6 Cr using the IPO proceeds.INR 177 Cr is allocated to meet the working capital needs of ArisInfra.ArisInfra also plans to invest INR 47.8 Cr in its subsidiary Buildmex-Infra Pvt Ltd.